Suzhou, China · Founded 2020 · Privately Held (backing)
Developer of a pulsed field ablation (PFA) system intended to treat Atrial fibrillation (A-fib). AccuPulse is based in Suzhou, China and was founded in 2020. It has raised $64.6 million.
Last price · $/share
—
Implied valuation
—
Total raised
$64.6M
Last round
—
Cap table — not yet on record
AccuPulse's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AccuPulse with a free account
·Watch AccuPulse: the Monday email on marks, rounds and moves
